Validation of blood transcriptional signatures for tubeculosis infection in Thai population  by Satproedprai, N. et al.
l of In
T
F
S
D
T
R
V
i
N
S
H
1
2
p
l
m
R
d
u
a
d
t
u
f
s
t
w
s
B
w
3
f
e
t
g
T
h
d
i
f
t
c
8
(
d
t
h
in various populations in order to timely implement appropriate
interventions to curb the menace of MDR-TB.15th ICID Abstracts / International Journa
ype: Poster Presentation
inal Abstract Number: 47.035
ession: Tuberculosis & Other Mycobacterial Infections
ate: Friday, June 15, 2012
ime: 12:45-14:15
oom: Poster & Exhibition Area
alidation of blood transcriptional signatures for tubeculosis
nfection in Thai population
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omboonyosdech1, S. Kumperasart1, S. Wattanapokayakit1, K.
iguchi2, H. Yanai2, N. Harada2, N. Wichukchinda1
National Institute of Health, Nonthaburi, Thailand
Research Institute of Tuberculosis, Tokyo, Japan
Background: Tuberculosis is one of the major global health
roblems, an estimate of 4,700deaths per day is related to Tubercu-
osis. Improvement in diagnostic tools, treatment and prevention
ethods are keys to the success in combating with tuberculosis.
ecently, transcriptome analysis of blood samples identiﬁed hun-
reds of gene transcripts associated with active tuberculosis. We
sedpublished transcriptomic data set available in public data base
nd re-analyze to narrow down to a small number of indepen-
ent transcript set and identify top gene expression signatures that
ogether can differentiate active tuberculosis from healthy individ-
als.
Methods: The minimum list of gene expression were selected
rom 393 transcripts based on three criteria 1) based on the feature
election methods called “Minimum redundancy feature selec-
ion from microarray gene expression data (mRMR)”, 2) Transcipt
ith highest differentiated power for identifying active tuberculo-
is from three datasets (training, test and validate data sets from
erry et al.) 3) Genes with evidence of association from genome-
ide association analysis of tuberculosis in Thais. Based on these
criteria, 12 TB-exclusive transcripts were selected to be tested
or their association with active tuberculosis status in Thais. We
mployed a multi-target TaqMan gene expression assay to validate
ranscriptional level of the 12 target genes and 2 internal control
enes HPRT1 andGAPDH. Blood sampleswere taken from38 active
B patients during their ﬁrst 2 month of anti-TB treatment and 36
ealthy individuals were recruited. Quantiferon assays (QFT) were
one in both TBpatients andhealthy controls in order to conﬁrmTB
nfection status. Healthy controls with QFT positive were excluded
rom the association analysis.
Results: From the 12 TB-blood signature transcripts, genes
hat are most differentially expressed between active TB as
ompared to normal individual are FCGR1B variant 1 (p=1.49×10-
), STAT1(p=5.66×10-7), FCGR1A (p=1.82×10-5) and GBP5
2.91×10-5).
Conclusion: These gene expression patterns have potential for
iagnosis of active TB especially when microbiological conﬁrma-
ion is not available.
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Prevalence of multidrug resistant Mycobacterium tuberculosis
in HIV seropositive and seronegative patients in Northern India
S. Sethi1,∗, S. Dhatwalia2, A.Mewara2, D. Gupta2, A.Wanchu2, H.
Nehra2, M. Sharma2
1 PGIMER, CHANDIGARH, Chandigarh, India
2 PGIMER, Chandigarh, India
Background: Multidrug resistant (MDR) and extensively-drug
resistant (XDR) tuberculosis (TB) are a serious threat to the national
TB control programs of developing countries, and the situation is
furtherworsenedby thehuman immunodeﬁciencyvirus (HIV)pan-
demic. The literature regarding MDR/XDR-TB is, however, scanty
from most parts of India. We carried out this study to assess the
prevalence of MDR/XDR-TB in new and previously treated cases of
pulmonary TB and in HIV seropositive and seronegative patients.
Methods: Sputum and blood specimens were obtained from
2100 patients suspected of pulmonary tuberculosis and subjected
to sputum microscopy and culture for TB, and HIV serology at
our tertiary care centre in north India. We analyzed various
parameters of thepatients’ viz. clinical presentation, radiology, pre-
vious treatment history, demographic and socioeconomic data and
microbiology results. The culture positive Mycobacterium tubercu-
losis isolates were subjected to drug susceptibility testing (DST) for
ﬁrst and second line anti-tuberculosis drugs.
Results: Of the 2100 specimens, 256 were smear positive
for acid-fast bacilli (AFB), 271 (12.9%) grew Mycobacterium spp.,
and Mycobacterium tuberculosis wasisolated in 219 specimens. In
the 219 patients infected with Mycobacterium tuberculosis, 20.1%
(44/219) were found to be seropositive for HIV. There were 121
newlydiagnosedand98previously treatedpatients, ofwhichMDR-
TBwas found to be associatedwith 9.9% (12/121) and 27.6% (27/98)
cases respectively. Among the 44 HIV seropositive patients there
were 12 (27.3%), while in the 175 HIV seronegative patients there
were 27 (15.4%) MDR isolates, though the difference was not found
to be statistically signiﬁcant (p =0.0664).
Conclusion: The present study demonstrated a high prevalence
of drug resistance amongst pulmonary TB isolates ofM. tuberculosis
from north India, however, we did not ﬁnd any XDR-TB isolate. The
prevalence of MDR-TB in HIV seropositive patients was not found
to be signiﬁcantly higher than seronegative individuals. The study
emphasized the need tomonitor the trends of drug resistance in TBhttp://dx.doi.org/10.1016/j.ijid.2012.05.970
